A large case-control study from China found that people with Parkinson’s disease were significantly less likely to test ...

Gastric cancer, the fifth most common malignancy worldwide and the fifth most common cause of cancer-related death, is ...

The global helicobacter pylori testing market is poised for significant growth, with projections estimating a market value of USD 380.3 million by 2032. Marking a substantial leap from its 2022 ...

Biohit’s latest innovation, the GastroPanel® quick test, represents the most advanced technology in the non-invasive serological diagnostics and screening of patients at high risk of gastric cancer.